Figure 1.
Kaplan-Meier analyses of overall survival (A) MFD-free survival and (B) by disease severity cohorts. Time of origin was the first allo-HSCT and patients alive without an event were censored at the last follow-up or at the time of study termination. MFD-free survival included survival without second allo-HSCT or major functional disabilities (MFDs).

Kaplan-Meier analyses of overall survival (A) MFD-free survival and (B) by disease severity cohorts. Time of origin was the first allo-HSCT and patients alive without an event were censored at the last follow-up or at the time of study termination. MFD-free survival included survival without second allo-HSCT or major functional disabilities (MFDs).

Close Modal

or Create an Account

Close Modal
Close Modal